Online Submissions

Already have a Username/Password for The BRICS Health Journal?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines

The BRICS Health Journal publishes original research articles, reviews, and letters to the editor on topics related to healthcare.

Only original works that have not been previously published, including those in another language, are accepted for consideration.

Submissions can be made online via the form available on the journal's website https://www.bricshealthjournal.com. 

Formatting guide

Article checklist (necessary requirements)

1. File requirements: format (except illustrations): .doc or .docx.
2. Text language: English
3. Text should be single-spacing (1.0).
4. Body text size should be 12 pt.
5. Articles should be no longer than 35.000 characters including spaces (excluding references):
   original research articles (20.000-25.000)
   reviews (30.000-35.000) and mini-reviews (12.000-18.000)
   letters to the editor (2.000-3.000) 
6. Title of the manuscript (up to 20 words)
7. Authors and affiliations.
8. Information about authors: surname, name.
9. Information about affiliation: name of the institution, address with country, city, postal code
10. Abstract (200 - 250 words).
11. Keywords (5-8 keywords that do not appear in the title itself).
12. Highlights (3 to 5 statments up to 25 words).
13. Additional information for the corresponding author: e-mail, address.
14. Ethics statements.
15. Data availability.
16. Competing interests. All authors are required to disclose any financial and personal relationships that might influence their work on the article.
17. Financial support. All sources of funding should be declared. If the work had no funding source, the authors should also state this.
18. Abbreviations list. For all abbreviations: do not abbreviate unless a term is used more than three times in the manuscript. In this case, the term should be spelled out the first time it is used in the text, followed by the abbreviation in parentheses, and then the abbreviation should be used for all other instanced in the text.
19. The main manuscript. References should be numbered consecutively in the order in which they are cited in the text. All references cited in the text must be both listed and cited by the reference number. Use Arabic numerals in brackets. Recommended number of references: original research articles (20-50), reviews (30-150), mini-reviews (12-30), letters to the editor (3-7). 
20. Authors' contributions. All authors should specify their contributions in accordance with the CRediT authorship contribution statement https://credit.niso.org/.
21. Information about the authors: academic degree, academic title, position, employment, ORCID.
22. References (Vancuver style)
23. All figures submitted must be owned solely by the author(s). Manuscripts should contain no more than 8 figures and tables. Figures should be in separate files in the highest resolution available (at least 300 dpi). Legends should be supplied for all figures. Figures submitted in colour will be published in colour.

The Editorial Board reserve the right to shorten and correct articles, change the design of graphs, figures and tables to bring them in line with the standard of the journal, without changing the meaning of the information provided.

All submitted articles are subject to plagiarism screening. In the event of excessive self-citation and/or inappropriate borrowing, the editors will act in accordance with the Committee on Publication Ethics (COPE) recommendations, as detailed in the following link: https://publicationethics.org

Disclaimer: all data regarding authors' names, geographical names and territorial jurisdiction are published exactly as they were submitted without changes by editorial office.

Updated 2026-07-20

Author Agreement (Word) 
ARRIVE 2.0 checklist 
STROBE checklist for case-control studies
STROBE checklist for cohort studies
STROBE checklist for cross-sectional studies
TREND checklist when reporting of intervention evaluation studies using nonrandomized designs
CONSORT checklist when reporting a randomised trial
SPIRIT checklist for Interventional Trials
PRISMA checklist for systematic review and meta-analysis
Guidelines for reporting artificial intelligence studies in medicines, pharmacotherapy, and pharmaceutical services
TRIPOD + AI statement- updated guidance for reporting clinical prediction models that use regression or machine learning methods

1. Copyright

Authors publishing manuscripts in this journal agree to the following: 

1. Authors reserve the copyright to the work and grant the journal the right to first publish the work under the terms of the Creative Commons Attribution 4.0 International License, which allows others to distribute this work with the obligatory preservation of references to the authors of the original work and the original publication in this journal.
2. The authors reserve the right to conclude separate arrangements regarding the non-exclusive distribution of the manuscript version published here (for example, posting it in the institute’s repository, publication in a book), regarding its original publication in this journal.
3. Authors have the right to post their work on the Internet (for example, in the institute’s repository or personal website) before and during the process of reviewing it with this journal, as this can lead to a productive discussion and more references to this work.

2. Authorship

2.1. The ICMJE recommends that authorship be based on the following 4 criteria:

• Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
• Drafting the work or revising it critically for important intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All of these conditions must be met.

Each author should be able to identify which co-authors are responsible for other specific parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors. All authors included in a paper must fulfil the criteria of authorship. Conversely, we also ask for assurance that there is no one else fulfilling the criteria that has been excluded as an author. Persons who do not meet all four criteria should be mentioned in the Acknowledgment section.

The journal follows the International Committee of Medical Journal Editors' (ICMJE ) recommendation that contributors who do not meet all the criteria for authorship should not be listed as authors but should be acknowledged https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html.

Acknowledgments in the article may be given to specific individuals and must include their full name, position, affiliation and a description of their contributions.

The BRICS Health Journal requires the corresponding author to obtain written permission from all acknowledged individuals and provide it to the Editorial office.

2.2 When authors submit any type of manuscript, they are required to disclose any financial and personal relationships that have influenced or could affect their work.

Each author must be familiar with and agree in advance with the list and order of the authorship of the manuscript before sending it to the journal. The authors and co-authors of the submitted manuscript should sign “Author Agreement” of the BRICS Health Journal which contains forms for copyright assignment, financial disclosures and authorship. All authors of the manuscript should indicate their contribution to the work on the manuscript and the presence or absence of a conflict of interest.

In case the authors want to make changes to the list of authors after it has been sent to the editor, according to the direction on ethics of scientific publications (COPE), It is necessary to provide the editor with a written justification for making changes to the author's team, with a detailed statement of the contribution of the added and/or deleted authors to the work on the manuscript, which must be signed by ALL the authors of this manuscript. If there are disagreements between the authors, consideration of the manuscript stops before an agreed decision within the group of authors. In cases where an article has already been published any requests for change of authorship approved by the editors lead to the publication of corrections. The editors reserve the right to demand additional documents confirming the legality of the changes in authorship (sample of written justification).

2.3. By submitting a manuscript to The BRICS Health Journal, authors certify that all submitted material, including text, figures, tables, raw data, and other accompanying files, is their original work, has been prepared independently, and is not simultaneously under review or submission to other journals.

The editorial team checks all incoming materials with the help of the Russian text plagiarism detection system "Antiplagiat" (https://www.antiplagiat.ru). Since November 2024, this system has a module "Duplicate Detector", which records cases when an identical or very similar document was previously checked by the system in another organization. In such a case, the mark "checked in another organization" appears in the report (https://antiplagiat.ru/detector-faq/).

The Editorial Office takes into account that the manuscript submitted by the authors may have been previously reviewed by another journal and not accepted for consideration for various reasons. In such cases, the authors are obliged to attach to the manuscript information about the fact of rejection, preferably in the form of an official letter from the Editorial Office of the corresponding journal. In the absence of such information, the Editorial Office has the right to request a written explanation. Failure to provide such an explanation may result in rejection of the manuscript without further consideration.  The Editorial Office considers simultaneous submission and duplication of publications unacceptable.

When reviewing a manuscript, the editorial team will check ALL text materials in using the Anti-Plagiarism System for illegal borrowings, incorrect borrowings, unfair self-citations, lack of necessary self-citations, signs of borrowings masking (including rewriting and attempts to circumvent the system), signs of generated text, translated borrowings (including machine and free translation). The check is performed by certified experts who have undergone advanced training in the use of the anti-plagiarism system.

For all illustrative materials (graphics, images, diagrams), the editorial team performs manual checks to detect illegal borrowing, incorrect borrowing, unfair self-citations, lack of required self-citations, and signs of image manipulation.

If violations of publication ethics are found, the Editorial Board acts in accordance with the rules of the Committee on Publication Ethics  (COPE). 

3. The author, is responsible for communication with the editors.

The correspondent author is the person responsible for communicating with the editors of the journal during the submission of the manuscript, peer review, and publication process. It is they who ensure the fulfilment of all technical requirements of the journal, such as providing detailed information about the authors, documents of approval from the ethics committee, documentation on the registration of clinical trials, the collection of forms and statements of conflict of interest. The correspondent author should be available throughout the process of submitting and reviewing the manuscript in order to respond to editorial requests on time. It should also be available after publication to respond to criticisms, requests from the editorial staff to provide additional data or other information if questions arise after publication.

Please note that in the electronic edition, the author who uploads the manuscript on the site from his personal account is considered as the author responsible for correspondence with the editors of the journal.

4. Preparing the manuscript 

4.1. Only original works that have not been previously published, including those in another language, are accepted for consideration.

The journal does not publish materials of defended dissertations, graduation qualification works.

We accept submissions online, via the form available at our website https://www.bricshealthjournal.com.

The size of the uploaded file containing the manuscript text must not exceed 100 MB.

The journal publishes original articles, reviews and mini-reviews, and letters to editor.

4.2. Preparing the manuscript, authors should adhere to the Recommendations for the Conduct, Description, Editing and Publication of Scientific Results in Medical Journals of the International Committee of Medical Journal Editors (ICMJE) http://www.icmje.org.

4.3. Cover letter

The BRICS Health Journal requires authors to submit a cover letter.

The cover letter should briefly discuss:

1. the importance of the submitted work 
2. why it is appropriate for the journal
3. type of manuscript (original study, review, or letter to the Editor) and design of the original study;

At the end of the letter, it is necessary to indicate that the work has not previously been published anywhere in any of the languages of the world, is not under consideration in other journals, and is not planned to be submitted to other journals until the completion of consideration in The BRICS Health Journal. Signatures of all authors of the manuscript under the cover letter are required.

4.4. Manuscript formatting requirements.

The BRICS Health Journal  has joined "Your Paper, Your Way" initiative, which simplifies the requirements for the format of a manuscript at the stage of submission to the journal.
You can submit your manuscript to the journal for initial consideration and peer review as a single Word file (the size of the uploaded file must not exceed 100 MB) without special editing in any format along with the necessary documents (cover letter and checklist for the appropriate study design). Tables and figures are included in the text of the manuscript and are accompanied by a legend. For more information, see Journal Policy - Simplified Submission Policy "Your Paper, Your Way".

Only when your manuscript is accepted for publication and moved to scientific editing, you will be asked to bring it into the "journal format" and provide all the elements necessary for the publication.

Manuscript formatting requirements before publication

The text should be printed on a white background in black Times New Roman font, size 12, after 1,0 intervals on a page of A4 size (210x295 mm) with 2 cm margins on all sides of the text. Alignment of the text in width, without hyphenation and a paragraph. Manuscript pages should be numbered sequentially.

All components of the article, including tables and illustrations (drawings, diagrams, photographs), must be in the same Word format file, with the extension docx. Tables and illustrations should be numbered in Arabic numerals, have a legend (Table 1 …. (the name), Figure 2 … (the name)) and have a link in the text (table. 1, fig. 2). The editors can request tables and illustrations in separate files.

The original article should not exceed 20,000-25,000 characters with spaces, reviews - of 30,000 - 35,000 characters with spaces, mini-reviews - 12,000-18,000 characters with spaces, letter to Editor - 2,000-3,000 characters with spaces.

The manuscript should include in one Word file:

1. Title, all author names and affiliations 
2. Abstract and keywords
3. Highlights
4. Full name and email of the author responsible for correspondence
5. Highlights
6. Manuscript text
7. Conflict of interest
8. Financial support 
9. Contribution of authors
10. Bibliography
11. Tables (with names)
12. Illustrations with captions
13. The lines and pages of the manuscript should be sequentially numbered (in Word: section "Layout" - "Line numbers" - "Continuously")
14. All components of the manuscript should be presented in English

4.5. The manuscript must be complete, unambiguous and consistent.

4.6. For an original study, the completed checklist and flowchart for the relevant study type should be attached in separate files. For example, for a randomized clinical trial - the CONSORT (Consolidated Standards Of Reporting Trials) checklist. Please fill out the checklist indicating line numbers.
When conducting studies involving animals, please include the ARRIVE checklist (the ARRIVE guidelines), filled out using a computer, along with the manuscript lines (as a separate PDF file). For systematic reviews and meta-analyses, please include the PRISMA checklist, etc. 

4.7. Original research is subject to statistical peer review. In case of questions about the results of the study, the editors have the right to request primary data that will not be transferred to third parties. Failure to provide data entails the removal of the manuscript from consideration. 

4.8.  When submitting the manuscript, the author must indicate whether he/she is a foreign agent according to the list of the Ministry of Justice of the Russian Federation https://minjust.gov.ru/ru/activity/directions/998/ .        

5. Components of the manuscript

5.1. All components of the manuscript should be presented in English.

• Type (original article, review, letter to Editor)
• Title (the first letter is uppercase, all other lowercase). It should be informative, brief enough (no more than 150 characters with spaces or 20 words) and reflect the results of the work. Avoid abbreviations in the title of articles.
• Initials and surnames of all authors;
• Name of the institution (s), the work was performed, the city and country, postal code;

An original article should come with a structured abstract and Highlights-key messages (3-8). Abstract should be of 200 to 250 words, including rubrics listed below 

A review should come with an unstructured abstract of 150 to 250 words and key messages - highlights (4-6).

A mini-review should come with an unstructured abstract of 150 to 250 words.

Abstract is not required for a letter to editor.

• Keywords;
• Contact information about the correspondent author:  name, surname, academic degree, position and the place of work (study) with address, contact number, e-mail.

5.2. List of abbreviations

Only generally accepted abbreviations should be used and only after the full name has been indicated. All abbreviations used in the article should be decrypted, except for the symbols of chemical elements and abbreviated names of well-known metric units. 

5.3. Highlights

Highlights are a brief list of the most significant and specific results of the study. They should be self-contained, informative, and understandable without reference to the full text of the article.

Each Highlight should:

• reflect one specific result of the study;
• contain an established fact (historical aspects, general discussions, etc. are not appropriate);
• convey, where possible, the element of scientific novelty or significance of the result;
• be formulated precisely, without introductory phrases or excessive explanations;
• corresponded with the results presented in the main text of the article.

Highlights should not repeat the abstract’s conclusions word for word. Some overlap in meaning is permissible, but generally, the set of highlights contains more specific facts than the conclusions in the abstract, since each highlight reflects a separate result.

Technical requirements for Highlights:

• Each highlight should consist of a single sentence.
• Length of one highlight should include no more than 25 words.
• Each highlight should reflect one specific result, element of scientific novelty, or practical significance of the study.
• Multiple independent results should not be combined in one Highlight.
• Statements should be made in the affirmative form.
• The number of highlights should be from 3 to 5.
• Abbreviations are not allowed.

Highlights are not required for a letter to editor.

5.4. The main text of the manuscript.

5.4.1. The description of the original study should not exceed 20 000 - 25 000 characters with spaces and have the following structure:

1. Introduction. It briefly highlights the status of the issue under consideration with links to the most significant publications, formulates the aim and justification of the need for the study.

2. Materials and methods. Information is provided in compliance with ethical requirements for research involving humans and animals. The date and number of the meeting of the local ethics committee should be indicated. A detailed description of the applied methods is given, which will allow other authors to repeat the experiment with the appropriate equipment. It is possible to indicate references to works with a more detailed description of the methods, however, the description given should be sufficient for a general understanding of the progress of the study. Quantitative and qualitative characteristics of patients (for clinical research) or laboratory animals (for experimental work) are described. A detailed description of statistical processing methods is also provided. Medicines should be indicated using INN (International Nonproprietary Name). When mentioning software, hardware and new drugs, the name of the manufacturer and the country where it is located is given in parentheses.

The basic principles of statistical processing of data you can find in the articles:

1. Bulanov N.М., SuvorovA.Yu., Blyuss O.B., Munblit D.B., Butnaru D.V., Nadinskaia M.Yu., Zaikin A.A. Basic principles of descriptive statistics in medical research. Sechenov Medical Journal. 2021; 12(3): 4–16.
   https://doi.org/10.47093/2218-7332.2021.12.3.4-16
2. Bulanov N.М., Blyuss O.B., Munblit D.B., Nekliudov N.A., Butnaru D.V., Kodzoeva Kh.B., Nadinskaia M.Yu., Zaikin A.A. Studies and research design in medicine. Sechenov Medical Journal. 2021; 12(1): 4–17.
   https://doi.org/10.47093/2218-7332.2021.12.1.4-17
3. Suvorov A.Yu., Bulanov N.М., Shvedova A.N., Tao E.A., Butnaru D.V., Nadinskaia M.Yu., Zaikin A.A. Statistical hypothesis testing: general approach in medical research. Sechenov Medical Journal. 2022; 13(1): 4–13. https://doi.org/10.47093/2218-7332.2022.426.08
4. Bulanov N.М., Blyuss O.B., Munblit D.B., Nazarenko T.V., Butnaru D.V., Nadinskaia M.Yu., Zaikin A.A. Venn diagrams and probability in clinical research. Sechenov Medical Journal. 2020; 11(4): 5  https://doi.org/10.47093/2218-7332.2020.11.4.5-14

In accordance with the Committee on Publication Ethics (COPE) guidelines on text recycling (self-plagiarism), authors must avoid duplicating substantial portions of text from their previously published works. While the reuse of standard methodological descriptions may sometimes be unavoidable, copying extensive blocks of text, protocols, or entire paragraphs is strictly prohibited; the manuscript must remain an independent, distinct scientific contribution.

However, if the submitted manuscript describes research that is a direct continuation, extension, or part of an ongoing project, series, or cycle of works, authors must explicitly state this relationship at the very beginning of the "Materials and Methods" section.

Instead of duplicating past technical descriptions, authors should provide a concise summary of the essential framework and explicitly direct the reader to the original publication based on the following principles:

• Established Protocols: Briefly state the core principles of the method and provide a direct citation to the previously published work.
• Modifications: Clearly highlight and describe in full detail any changes, optimizations, or variations introduced to the methodology for the current study.
• Sufficiency of Information: Ensure the section contains enough summary detail and contextual information so that the current study remains reproducible and understandable for basic comprehension.

Authors may use the following templates to state this continuity at the beginning of their methodology section:

“The present study represents a continuation of our previously published research [Citation].“

“This article reports new results obtained using the methodology described in the earlier publication [Citation], with the specific modifications detailed below.”

Ultimately, providing these explicit cross-references and citations to previously published works ensures a complete understanding of the methodological framework, allowing readers to seamlessly trace the technical continuity of the entire research cycle.

3. Results. They should be presented in a logical sequence in the text, tables and figures. The text should clearly indicate a link to tables and figures. All data from tables and figures should not be repeated in the text, only the most important ones should be mentioned. The figures should not duplicate the data given in the tables. The name of the drawings and their legends under the appropriate numbering must be presented on a separate page. Measurement values must comply with the International System of Units (SI). Chemical formulas, tables, doses of drugs should be carefully verified.

4. Discussion. It is necessary to highlight new and important aspects of the results of your research and compare them with the data of other studies if any. Do not repeat the information in the previous sections.

5. Conclusion (conclusions). It should include brief conclusions and sound recommendations, as well as directions for future research.

Current international standards of presenting the results of original research you can find at website Equator network https://www.equator-network.org/reporting-guidelines/ :

CONSORT (Consolidated Standards Of Reporting Trials)

TREND (Transparent Reporting of Evaluations with Nonrandomized Designs).

STROBE (Strengthening the Reporting of Observational Studies in Epidemiology).

STARD (Standards for Reporting of Diagnostic Accuracy).

TRIPOD (The Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis).

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses, 

ARRIVE (Animal Research: Reporting of In Vivo Experiments) https://arriveguidelines.org/resources/author-checklists

Original research is subject to statistical peer review. In case of questions about the results of the study, the editors have the right to request primary data that will not be transferred to third parties. Failure to provide data entails the removal of the manuscript from consideration. 

5.4.2. Review should not exceed 30.000 - 35.000 characters with spaces and reflect the current status of the problem.

5.4.3. Letter to Editor should comment on articles published in The BRICS Health Journal during the last year. 

The Letter to Editor should not exceed not exceed 2.000 - 3.000 characters with spaces (excluding the title, bibliography and information about authors), 3 authors, one figure or table (if necessary).

The bibliography should include a link to the commented article and contain no more than 3-7 sources.

5.4.4. A mini-review should not exceed 12,000 — 18,000 characters with spaces accordingly and should reflect the current status of the problem.

5.5. Conflict of interest 

ALL authors should disclose the existence of a conflict of interest. Conflict of interest implies the presence of any connections and/or personal interests that could potentially affect the results, interpretation of the received data, their objective perception, in particular financial relations and cooperation with any organizations (for example, receiving fees, educational grants, participation in expert councils, membership, labour relations, consulting work or other interests) or non-financial interest (for example, personal or professional relationships, etc.), concerning the issues discussed in the article and/or materials. All significant conflicts of interest should be reflected in the manuscript (after the text of the article, before the list of references).

In the absence of a conflict of interest, the following should be stated:

Conflict of interests. The authors declare that there is no conflict of interest.

5.6. Bibliography / References

In the text of the article, bibliographic references are given in Arabic numerals in square brackets, for example, [1]. All works are listed in citation order in the text. Individual surnames of authors mentioned in the text must be preceded by initials (the names of foreign authors are given in the original transcription). 

It is recommended to include in the bibliography relevant works published in the last 5 years that have digital identifiers: DOI, PMID. For books and monographs, the ISBN is mandatory. Sources without these identifiers, sources in the form of links to websites will be removed from the reference list. 
The reference list should not include unpublished papers and preprints, dissertations, textbooks, conference proceedings, as it is difficult to familiarize with them.

The bibliography for the original article is limited to 20-50 sources, for the review 30 – 150, for a mini-review - 12-30, for the Letter to Editor – 3-7.

The bibliography is printed on a new page. Each source is indicated on a new line with a serial number. The design of the References is carried out in accordance with the requirements of the Vancouver Style.

The bibliographic description includes:

1. Surname and initials of the author (s);
2. Title of publication;
3. Imprint (place of publication, name of the publisher, year of publication, volume, number, pages);
4. DOI (if any);
5. PMID (if any).

Examples:

1. Cintrón-Colón A.F., Almeida-Alves G., Boynton A.M., et al.GDNF synthesis, signaling, and retrograde transport in motor neurons. Cell Tissue Res. 2020 Oct; 382(1): 47–56. https://doi.org/1007/s00441-020-03287-6 .  Epub 2020 Sep 8. PMID: 32897420; PMCID: PMC7529617 
2. Hayreh S.S. Structure of the optic nerve. Ischemic optic neuropathies. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. P. 7-34. https://doi.org/10.1007/978-3-642-11852-4.ISBN 978-3-642-11849-4. e-ISBN 978-3-642-11852-4

References to electronic resources are made in the form of footnotes:

³ World Health Organization, International Agency for Research of cancer: Cancer Today –https://gco.iarc.fr/today/online-analysis-piev=2020&mode=population&mode_population=continents&population=900&populations=900&key=total&sex=0&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0 (access data: 10.11.2022).

If the team of authors includes more than 4 authors, indicate the first three authors and then put “et al.” All references to journal publications must contain DOI and PMID. You can check for a DOI article at https://search.crossref.org and for a PMID at PubMed. Please pay attention to the correct design DOI: https://doi.org/10.1016/S1473-3099(08)70255-X. Only a hyphen (not a dash) is used in the DOI body.

5.7. Information about ALL authors in English is indicated: 

Surname, Name, academic degree and title (if any), position, place of work (or study), ORCID;

In the absence of an ORCID number, you should obtain it by registering on the website https://orcid.org

ORCID is a register of unique identifiers for scientists and, at the same time, an appropriate method linking research activities with these identifiers. To date, this is the only way to uniquely identify the scientist’s personality.

5.8. Specific author contributions should be provided for all authors. 

• study concept and design,
• acquisition of data, analysis and interpretation of data,
• statistical analysis,
• drafting the manuscript.
• critical revision of the manuscript for important intellectual content

All authors should approve the final version of the manuscript and take responsibility for all aspects of the work. 

Persons who do not meet all four criteria of authorship should be mentioned in the Acknowledgment section.

5.9. Disclose any financial and personal relationships that have influenced or could affect your work.

5.10. Tables

Tables are given in the text of the manuscript. Each table should have a name (without abbreviations) and serial number (in Arabic numerals), following the appearance in the text. Each column in the table should have a short heading (abbreviations can be used).

All clarifications, including a breakdown of abbreviations, should be placed in footnotes (notes to the table). The statistical methods used to represent data variability and significance of differences should be indicated.

The number of tables should be absolutely necessary. Manuscripts should contain no more than 8 figures and tables. 

5.11. Illustrations, titles and captions for illustrations 

All illustrations should be included in the manuscript. 

Captions and legends need to be printed below each illustration. The caption should consist of the name and the legend (explanations of the parts of pictures, schemas, photographs, symbols, arrows and other details). In captions for microphotographs the zoom rate and the method of colouring should be specified.

The illustration should contain a minimum amount of legends, all annotations should be included in the caption below the illustration.

Places for all illustrating materials in the text are being specified in the order of citing (for example, Fig.1). The publisher provides printing of coloured as well as black and white photographs. Figures submitted in colour will be published in colour.

The number of photographs should be just absolutely necessary. Manuscripts should contain no more than 8 figures and tables. Figures should be in separate files in the highest resolution available (at least 300 dpi).

After successful peer review and before acceptance of the manuscript for publication, authors should provide figures in separate files, with the name of each file including the figure type and number, e.g: Figure_1, Scheme_2. Acceptable formats: .ppt, .pptx, .tif, .tiff, or .jpeg. For graphic files, the resolution should be at least 300 dpi, size 10x10cm.  
All captions on images should be in editable format. You may also submit an image as a PowerPoint slide with captions superimposed on the image.

5.12. Manuscripts not meeting the requirements above will not be considered.

5.13. The Editorial Board reserves the right to shorten and correct articles, change the design of graphs, figures and tables to bring them in line with the standard of the journal, without changing the meaning of the information provided.

5.14. According to the policy of the journal, all manuscripts accepted for consideration are double-blind peer-reviewed by 2 reviewers, full texts of the reviews for all published articles are uploaded along with the articles to the Scientific Electronic Library eLIBRARY.ru and are opened for library readers, the personal data of reviewers remain closed.

Copyright Notice

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Privacy Statement

Specified when registering the names and addresses will be used solely for technical purposes of a contact with the Author or reviewers (editors) when preparing the article for publication. Private data will not be shared with other individuals and organizations.